Related by context. Frequent words. (Click for all words.) 58 Can Fite 58 orally bioavailable 58 DB# [003] 56 PF # [001] 56 AP# [003] 55 BAY #-# 55 PRX # 54 Phase IIa clinical 54 PRX# 54 phase IIa 54 Phase 2a 54 XL# [003] 54 Phenoptin 54 Phase IIa trial 53 NGX# 53 Phase Ib 53 tezampanel 53 methylnaltrexone 53 INCB# [002] 53 oral formulation 52 diabetic neuropathic pain 52 injectable formulation 52 Phase 2b 52 Phase 2a trial 52 PXD# 52 CA4P 52 voclosporin 52 confirmatory Phase III 52 investigational oral 52 Phase 2a clinical 52 Phase 2b study 52 humanized monoclonal antibody 52 HspE7 51 VEGF Trap 51 Phase IIa 51 diabetic macular edema DME 51 IND enabling 51 Zerenex 51 Atiprimod 51 IMGN# 51 ZYBRESTAT 51 Phase 1b clinical 51 OXi# 51 phase IIb 51 tamibarotene 51 Acute Myeloid Leukemia AML 51 Phase III clinical 51 Phase IIb 51 tesetaxel 50 Phase III 50 HuMax CD# 50 alogliptin 50 investigational 50 oritavancin 50 eculizumab 50 metastatic renal cell carcinoma 50 investigational compound 49 Phase II 49 TREANDA 49 relapsed multiple myeloma 49 MGCD# [001] 49 PEG Interferon lambda 49 Phase III Trial 49 Alpharadin 49 laquinimod 49 MDV# 49 crofelemer 49 perifosine 49 Clinical Study 49 Phase IIb clinical 49 RDEA# 48 Phase 2b trial 48 blinatumomab 48 PS# [001] 48 Cimzia ® 48 phase 2a 48 Phase 2b clinical 48 Synavive 48 dose escalation trial 48 Phase III trials 48 Phase 1b 48 Initiates Phase 48 Completes Enrollment 48 SILENOR TM 48 tgAAC# 48 TELCYTA 48 Orphan Drug 48 Investigational 48 TG# [001] 48 taliglucerase alfa 48 drug conjugate 48 ATryn R 48 radiolabeled 48 carfilzomib 48 dabigatran etexilate 47 MOZOBIL 47 sapacitabine 47 ONCONASE 47 Nimotuzumab 47 Iluvien 47 multiple ascending dose